RDF/XML JSON-LD N3/Turtle RDF/JSON

Melguizo Alonso, Consolación Author

Open Access

E phage gene transfection associated to chemotherapeutic agents increases apoptosis in lung and colon cancer cells

  • Rama A.R.
  • Prados J.
  • Melguizo C.
  • Álvarez P.J.
  • Ortiz R.
  • Madeddu R.
  • Aranega A.
... View more Collapse

Bioengineered Bugs - 18/7/2011

10.4161/bbug.2.3.15533

Cite count: 4 (Scopus)
  • CiteScore: 3.7 (2015)
Open Access

Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells

  • Rama A.R.
  • Prados J.
  • Melguizo C.
  • Burgos M.
  • Alvarez P.J.
  • Rodriguez-Serrano F.
  • Ramos J.L.
  • Aranega A.
... View more Collapse

Biomedicine and Pharmacotherapy - 1/7/2011

10.1016/j.biopha.2011.01.002

Cite count: 10 (Web of Science) 9 (Scopus)
  • JCR Quartile: Q4 (2011)
  • SJR Quartile: Q2
  • JCR Impact Factor: 2 (2011)
  • Category normalized Impact: 0.337 (2011)
  • CiteScore: 9.3 (2020)
  • SJR: 0.785 (2011
  • SNIP: 1.014 (2011
  • JCR 5-year Impact Factor: 2.34
  • JCR Categories: PHARMACOLOGY & PHARMACY
  • SJR Categories: Medicine (miscellaneous) (Q2); Pharmacology (Q2)

gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway

  • Boulaiz, Houria
  • Alvarez, Pablo J.
  • Prados, Jose
  • Marchal, Juan
  • Melguizo, Consolacion
  • Carrillo, Esmeralda
  • Peran, Macarena
  • Rodriguez, Fernando
  • Ramirez, Alberto
  • Ortiz, Raul
  • Aranega, Antonia
... View more Collapse

International Journal of Molecular Sciences - 1/11/2011

10.3390/ijms12117445

Cite count: 5 (Web of Science) 7 (Scopus)
  • JCR Quartile: Q4 (2011)
  • SJR Quartile: Q1
  • JCR Impact Factor: 2.598 (2011)
  • Category normalized Impact: 0.112 (2011)
  • JCR 5-year Impact Factor: 2.617
  • JCR Categories: CHEMISTRY, MULTIDISCIPLINARY
  • SJR Categories: Computer Science Applications (Q1); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3); Molecular Biology (Q3)

Multidrug resistance and rhabdomyosarcoma (review)

  • Melguizo C.
  • Prados J.
  • Rama A.R.
  • Ortiz R.
  • Álvarez P.J.
  • Fernández J.E.
  • Aranega A.
... View more Collapse

Oncology Reports - 1/10/2011

10.3892/or.2011.1347

Cite count: 13 (Web of Science) 12 (Scopus)
  • JCR Quartile: Q4 (2011)
  • SJR Quartile: Q1
  • JCR Impact Factor: 1.835 (2011)
  • Category normalized Impact: 0.209 (2011)
  • CiteScore: 6.9 (2020)
  • SJR: 0.882 (2011
  • SNIP: 0.681 (2011
  • JCR 5-year Impact Factor: 1.827
  • JCR Categories: ONCOLOGY
  • SJR Categories: Medicine (miscellaneous) (Q1); Oncology (Q2); Cancer Research (Q3)

Development of patents and clinical trials on regenerative therapy: Gene therapy

  • Prados J.
  • Boulaiz H.
  • Alvarez P.J.
  • Melguizo C.
  • Rodríguez-Serrano F.
  • Marchal J.A.
  • Perán M.
  • Caba O.
  • Hita F.
  • Aranega A.
... View more Collapse

Recent Patents on Regenerative Medicine - 1/1/2011

10.2174/2210297311101020182

Cite count:
  • CiteScore: 1.1 (2016)
  • SJR Categories: Cell Biology; Developmental Biology; Developmental Neuroscience

Regenerative therapies in cartilage and bone: Current patents, technologies, and emerging applications

  • Rodríguez-Serrano F.
  • Álvarez P.
  • Marchal J.
  • Perán M.
  • Vázquez-Vázquez M.
  • Prados J.
  • Boulaiz H.
  • Melguizo C.
  • Vélez C.
  • Carrillo E.
  • Aránega A.
... View more Collapse

Recent Patents on Regenerative Medicine - 1/1/2011

10.2174/2210296511101020134

Cite count:
  • CiteScore: 1.1 (2016)
  • SJR Categories: Cell Biology; Developmental Biology; Developmental Neuroscience

Drug Resistance Induced by Plasmatic Concentrations of Paclitaxel and Carboplatin in Cancer Cell Lines

  • Luque, R.
  • Delgado, J.
  • Gonzalez, E.
  • Prados, J.
  • Melguizo, C.
  • Valdivia, J.
  • Martinez, J.
  • Ortega, J.
  • Ortiz, R.
  • Aranega, A.
... View more Collapse

EUROPEAN JOURNAL OF CANCER - 09/2011

10.1016/s0959-8049(11)70788-2

  • SJR Quartile: Q1
  • JCR Impact Factor: 5.536 (2011)
  • JCR 5-year Impact Factor: 4.781
  • JCR Categories: ONCOLOGY
  • SJR Categories: Cancer Research (Q1); Oncology (Q1)

Drug resistance induced by plasmatic concentrations of paclitaxel and carboplatin

  • Luque, R.
  • Gonzalez Flores, E.
  • Delgado, J. R.
  • Prados, J. C.
  • Melguizo, C.
  • Conde, V.
  • Gonzalez Astorga, B.
  • Ortiz, R.
  • Rama, A.
... View more Collapse

JOURNAL OF CLINICAL ONCOLOGY - 20/05/2011

10.1200/jco.2011.29.15_suppl.e13036

  • SJR Quartile: Q1
  • JCR Impact Factor: 18.372 (2011)
  • JCR 5-year Impact Factor: 16.762
  • JCR Categories: ONCOLOGY
  • SJR Categories: Cancer Research (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)
Open Access

Nanomedicine: Application Areas and Development Prospects

  • Boulaiz, Houria
  • Alvarez, Pablo J.
  • Ramirez, Alberto
  • Marchal, Juan A.
  • Prados, Jose
  • Rodriguez-Serrano, Fernando
  • Peran, Macarena
  • Melguizo, Consolacion
  • Aranega, Antonia
... View more Collapse

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1/05/2011

10.3390/ijms12053303

Cite count: 100 (Web of Science) 92 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 2.598 (2011)
  • JCR 5-year Impact Factor: 2.617
  • JCR Categories: CHEMISTRY, MULTIDISCIPLINARY
  • SJR Categories: Computer Science Applications (Q1); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3); Molecular Biology (Q3)

TRANSFECTION OF THE GENE E AND LATER APPLICATION OF CYTOTOXIC DRUGS IN THE TREATMENT OF COLON CELLS CANCER

  • Rama, A.
  • Melguizo, C.
  • Prados, J.
  • Ortiz, R.
  • Rodriguez-Serrano, F.
  • Marchal, J.
  • Carrillo, E.
  • Boulaiz, H.
  • Archla, F.
  • Picon, M.
  • Aranega, A.
... View more Collapse

ANNALS OF ONCOLOGY - 2010

  • SJR Quartile: Q1
  • JCR Impact Factor: 6.452 (2010)
  • JCR 5-year Impact Factor: 5.66
  • JCR Categories: ONCOLOGY
  • SJR Categories: Hematology (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)

Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy

  • Marchal J.
  • García M.
  • Boulaiz H.
  • Perán M.
  • Álvarez P.
  • Prados J.
  • Melguizo C.
  • Aránega A.
... View more Collapse

Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012

10.1007/978-94-007-2415-0_15

Cite count:

The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy

  • Boulaiz, H
  • Prados, J
  • Melguizo, C
  • Marchal, JA
  • Carrillo, E
  • Velez, C
  • Fernandez, JE
  • Alvarez, L
  • Caba, O
  • Aranega, A
... View more Collapse

CELLULAR AND MOLECULAR BIOLOGY - 06/2003

  • JCR Quartile: Q4 (2003)
  • SJR Quartile: Q1
  • JCR Impact Factor: 1.153 (2022)
  • SJR Categories: Medicine (miscellaneous) (Q1)

This author has no conferences.

This author has no patents.

Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review

  • Lidia Gago
  • Francisco Quiñonero
  • Gloria Perazzoli
  • Consolacion Melguizo
  • Jose Prados
  • Raul Ortiz
  • Laura Cabeza
... View more Collapse

Pharmaceutics - 13/06/2023

10.3390/pharmaceutics15071958

Cite count: 2 (Web of Science) 1 (Scopus)
Open Access

Synthesis, solubility and antitumor activity of maslinic acid derivatives

  • Fuentes-Rios, D.
  • Cepero, A.
  • Garcia-Castro, M.
  • Contreras-Caceres, R.
  • Lopez-Romero, J. M.
  • Luque, C.
  • Cabeza, L.
  • Melguizo, C.
  • Prados, J.
... View more Collapse

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022

10.1016/j.ejmcr.2022.100032

Cite count: 4 (Web of Science)

Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)

  • Ballesteros A.
  • Hernández R.
  • Perazzoli G.
  • Cabeza L.
  • Melguizo C.
  • Vélez C.
  • Prados J.
... View more Collapse

CANCER GENE THERAPY - 1/1/2020

10.1038/s41417-020-0166-y

Cite count:
  • JCR Impact Factor: 5.987 (2020)
  • CiteScore: 8.1 (2020)
  • SJR: 1.535 (2020
  • SNIP: 1.113 (2020
  • JCR 5-year Impact Factor: 5.358
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Open Access

Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives

  • Hernández R.
  • Sánchez-Jiménez E.
  • Melguizo C.
  • Prados J.
  • Rama A.R.

BMB Reports - 1/1/2018

10.5483/bmbrep.2018.51.11.116

Cite count: 19 (Web of Science) 12 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 2.966 (2018)
  • CiteScore: 6 (2020)
  • SJR: 1.082 (2018
  • SNIP: 0.952 (2018
  • JCR 5-year Impact Factor: 2.838
  • JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
  • SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)

Scopus: 27

Web of Science: 30

Scopus: 78

Web of Science: 90

Last data update: 6/29/24 7:50 AM
Next scheduled update: 7/6/24 3:00 AM